Medindia
Medindia LOGIN REGISTER
Advertisement

QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH

Monday, September 3, 2007 General News
Advertisement
LES ULIS, France, September 3

- QUANTEL has Entered Into the Final Phase of the Negotiations in View ofAcquiring the Company WaveLight Aesthetic GmbH
Advertisement

A strong complementarity

This company, a subsidiary of the German company WaveLight AG, isspecialized in Dermatology/Aesthetic lasers. It is based in Germany, inErlangen, near Nuremberg and its revenues are estimated of approx. 10MEUR forthe fiscal year 2006/2007 ended July 31, 2007.
Advertisement

Its product line is very complementary with Quantel Medical's with, inparticular, lasers for tattoo removal, hair removal and skin resurfacing.

A powerful and profitable Dermatology division

The combination of Quantel Medical's Dermatology's activities with thoseof WaveLight Aesthetic will create a Dermatology division with a verycomplete product offering and which could make more than 20MEUR in sales in2008. This would lead to good profitability in a very large and fast growingmarket.

Achieving the objectives set by WaveLight Aesthetic's management, whowill remain in place, should be immediately accretive to the Group's profits.

Both parties intend to sign final agreements before the end of September2007.

The terms and conditions of the financing for this acquisition are stillbeing negotiated. They will be published soon.

ABOUT THE QUANTEL GROUP

Founded in 1970, the QUANTEL Group has over the last 10 years establisheditself as one of the world's leading specialists for scientific (researchlaboratories, universities), industrial (micromachining, metrics, military)and medical (ophthalmology, dermatology) laser technologies.

Located in France and the US, through its Big Sky Laser subsidiary, theQUANTEL Group generated EUR2.1 million in net income in 2006 and EUR41.4million in revenues, with 81% on international markets, split betweenscientific and industrial applications (51%) and medical clients (49%) forlasers.Alain de Salaberry Chairman and Chief Executive Officer T: +33-1-69-29-17-00 [email protected] Mathieu Calleux Investor Relations T: +33-1-53-65-37-91 [email protected] Philippe Melikian Chief Financial Officer T: +33-1-69-29-17-00 [email protected] Marie Ein Press Relations T: +33-1-53-65-37-91 [email protected]

SOURCE QUANTEL
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close